Evidence map›Paper›PMID 24778754›Full record

ArticleThe Pan African medical journal2013

Evaluation of antiretroviral therapy (ART) provision in an early cohort of patients initiating ART in Ghana.

Sally-Ann Ohene, Nii Akwei Addo, Francisca Zigah, Morkor Newman, Margaret Lartey, Maite Alfonso Romero, Sampson Ofori, Tania Sheriff, Tom Ndanu

Abstract read
In one paragraph

Article in The Pan African medical journal, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sally-Ann OheneWorld Health Organization Ghana Country Office, Accra, Ghana.
Nii Akwei AddoNational AIDS/STI Control Programme, Ghana Health Service, Accra, Ghana.
Francisca ZigahKorle Bu Teaching Hospital, Accra, Ghana.
Morkor NewmanWorld Health Organization Inter-country Support Team, Harare, Zimbabwe.
Margaret LarteyDepartment of Medicine, University of Ghana Medical School, Accra, Ghana.
Maite Alfonso RomeroSt Dominic's Hospital, Akwatia, Ghana.
Sampson OforiKoforidua Regional Hospital, Koforidua, Ghana.
Tania SheriffOdorna Clinic, Accra, Ghana.
Tom NdanuUniversity of Ghana Dental School, Accra, Ghana.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAgainst the background of Ghana's ART program which scaled up rapidly since inception in 2003, the study assessed outcomes of an early cohort of patients initiating ART.

methodsTHE STUDY UTILIZED THE FOLLOWING

methodsa cross-sectional study involving patient interviews using a structured questionnaire, a review of records and a retrospective cohort analysis of adults initiating ART between 2003 and 2008 from four selected clinics.

resultsThe 683 study participants consisted of 464 females (67.9%) and the mean age was 41 years. Mean duration of treatment was 25 months (SD =13). More than 95% were on a regimen as per national guidelines. Ninety-five (14.1%) of the respondents had one or two drugs substituted. Seventy-three% of the substitutions were due to adverse drug reactions. On at least one occasion, over half (350) had defaulted on a clinic appointment. In the 3 months preceding the survey, 21.4% (146) had missed treatment doses. About 49% (334) had challenges meeting financial obligations related to care. The median weight increased by 5.9 kg and 8.0 kg at 6 and 12 months after initiating ART respectively over the median baseline weight of 54 kg, (p-value = 0.001). The median CD4 count increased by 128, 170 and 256 cells/µl respectively at 6, 12 and 24 months from the median baseline of 125 cell/µl, (p-value = 0.035).

conclusionThis study of Ghanaian PLHIV on ART from four facilities showed encouraging immunological and clinical outcomes. There were however issues of appointment default, sub-optimum adherence to treatment and cost of care barriers needing attention.

Indexed as

AdultAnti-HIV AgentsAnti-Retroviral AgentsCohort StudiesCross-Sectional StudiesDrug MonitoringDrug-Related Side Effects and Adverse ReactionsDrug SubstitutionFemaleGhanaHealth Services AccessibilityHIV-1HIV InfectionsHumansMaleMiddle AgedAnti-HIV AgentsAnti-Retroviral Agentsantiretroviral treatmentclinicalGhanaimmunologicaloutcomes

Identifiers

PMID24778754
PMCPMC3998899

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.